Panax ginseng shows highest effectiveness in treating Alzheimer's. Learn more about AVXL's blarcamesine and SAVA's simufilam ...

On Friday, Anavex Life Sciences Corp (AVXL) stock saw a modest uptick, ending the day at $9.24 which represents a slight increase of $1.60 or 20.94% from the prior close of $7.64. The stock opened at ...

The stock is currently trading at just under $27. AVXL: Anavex Life Sciences rounds out the list as another heavily-shorted ...

Here Are Other Stocks Moving In Monday's Mid-Day Session Avi Kapoor Neurodegenerative Disease-Focused Anavex Life Sciences' Alzheimer's Candidate Slows Disease Progression By Almost 39% Anavex ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Cantor Fitzgerald has recently reduced Anavex Life Sciences Corp (AVXL) stock to Neutral rating, as announced on December 6, 2022, according to Finviz. Earlier, on June 23, 2022, Berenberg had ...

Meanwhile, Eli Lilly, AC Immune, Johnson & Johnson, Merck & Co, Anavex and Axon Neurosciences have other anti-tau drugs in early-stage clinical testing. Roche’s head of pharma partnering ...

About Anavex Life Sciences Corp.